Biome International Market Update and Health Canada approvals

● Following January 2024 launch into health retail in the UK and Ireland, Biome
expects FY24 International sales revenue to surpass $850k
● Biome expects FY24 international sales revenue to grow 85%+ vs PCP (FY23 $459k)
● Biome secures approval from Health Canada for eight product registrations, with
more to follow in Q4 FY24
● Biome commences exploration into Western European markets for FY25 expansion
● Biome expects a test market launch into North America via Canada in H2 FY25